Dividend Distribution - In 2023, Yunnan Baiyao's dividend plan was to distribute 20.77 CNY per 10 shares, totaling 3.706 billion CNY, which accounted for 90.53% of the net profit attributable to shareholders [2] - For 2024, the company plans to distribute 12.13 CNY per 10 shares, with a total dividend amount of 2.164 billion CNY, representing 50.02% of the net profit for the first three quarters [2] - Since its listing in 1993, Yunnan Baiyao has distributed dividends for 31 consecutive years, with cumulative cash dividends exceeding 26.6 billion CNY [2] Pharmaceutical Business Performance - In the first half of 2024, sales revenue of Yunnan Baiyao aerosol exceeded 1.2 billion CNY, with a year-on-year growth of over 30% [3] - The pharmaceutical division aims to enhance its brand positioning in pain management and optimize business layout through online and offline integration [3] - The company plans to establish "pain service centers" in community pharmacies to provide initial treatment services and meet diverse pain management needs [3] Oral Care Product Sales - Yunnan Baiyao toothpaste maintained a leading market share in the domestic oral care sector in the first half of 2024 [4] - During the "618" shopping festival, Yunnan Baiyao's oral health brand ranked as the top online oral care brand [4] - The company implemented targeted marketing campaigns to enhance brand recognition and consumer engagement, achieving over 3.6 billion total exposures [5] Channel Development Strategies - The company has established a comprehensive marketing network covering various medical institutions and retail pharmacies across China [6] - Yunnan Baiyao collaborates with over 5,000 leading chain pharmacies and has a strong presence in regions like East China, Hunan, Hubei, and Yunnan [6] - The company is actively expanding its online sales channels through partnerships with major e-commerce platforms and optimizing traditional and emerging retail channels [6]
云南白药(000538) - 2025年1月7日调研活动附件之投资者调研会议记录